Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€52.00

€52.00

0.980%
0.5
0.980%
€71.01
 
03.06.25 / Tradegate WKN: A0LFMZ / Symbol: RDNT / Name: RadNet / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction

Radnet Inc. Stock

Radnet Inc. gained 0.980% compared to yesterday.
Radnet Inc. is currently one of the favorites of our community with 15 Buy predictions and no Sell predictions.
As a result the target price of 71 € shows a positive potential of 36.54% compared to the current price of 52.0 € for Radnet Inc..

Pros and Cons of Radnet Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Radnet Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Radnet Inc. 0.980% 2.970% 9.705% -4.587% -23.529% - -
Surgery Partners Inc -1.940% 0.000% 0.000% -16.529% 2.020% -45.198% 66.942%
Addus Homecare Corp. -2.550% -2.051% 2.139% -8.173% -20.417% 24.837% 7.910%
Capital Senior Living Corp. -0.940% -2.778% 0.000% -17.323% -3.670% -12.500% 166.667%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

RadNet, a prominent player in the Healthcare Providers & Services industry with the US trading symbol RDNT, showcases a distinctly mixed financial performance. While the company has exhibited steady growth in its total assets and revenue, some critical ratios and financial indicators present a more nuanced picture. To better understand the intricacies of RadNet's financials, let's examine the pros and cons of its various financial aspects.

Revenue growth: Over the past three years, RadNet's total revenue has risen consistently. From a total revenue of $1.07 billion in 2020, the company experienced growth, reaching $1.31 billion in 2021 and further to $1.43 billion in 2022. This revenue growth indicates a positive market presence and expanded operations.

Increased total assets: A similar trend is observed in the company's total assets, with figures growing from $1.79 billion in 2020 to $2.06 billion in 2021 and even further to $2.43 billion in 2022. This growth can imply that the company is making considerable investments to enhance its operational capabilities.

Comments

Prediction Buy
Perf. (%) 10.17%
Target price 65.601
Change
Ends at 11.04.26

RadNet, Inc. (NASDAQ: RDNT) had its price target lowered by analysts at Truist Financial Co. from $88.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for RDNT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 8.33%
Target price 55.422
Change
Ends at 24.03.26

RadNet, Inc. (NASDAQ: RDNT) had its price target lowered by analysts at Barclays PLC from $74.00 to $60.00. They now have an "overweight" rating on the stock.
Ratings data for RDNT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 6.56%
Target price 60.632
Change
Ends at 05.03.26

RadNet, Inc. (NASDAQ: RDNT) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $65.00 price target on the stock, down previously from $85.00.
Ratings data for RDNT provided by MarketBeat
Show more